A study supported by the National Institute of Health found a common drug combination therapy for treating idiopathic pulmonary fibrosis is not any more affective than a placebo in preserving lung ...

Rare lung diseases affect people nationwide, yet many patients go undiagnosed or misdiagnosed for years. One rare lung disease that illustrates the challenges of timely diagnosis is autoimmune pulmona ...

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

Add Yahoo as a preferred source to see more of our stories on Google. Oct. 31—(StatePoint) Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH).

RILD in NHL patients presents as lung disease, organizing pneumonia, and nonspecific interstitial pneumonia, with 179 pathogenic microorganisms identified. The study systematically characterized RILD ...

CHICAGO, July 8, 2025 /PRNewswire/ -- The American Lung Association is launching a new campaign to support and empower individuals living with chronic obstructive pulmonary disease (COPD) in rural and ...

A new development in wireless sensing technology that can reliably screen for five common pulmonary diseases could lead to new forms of touch-free diagnostics. Subscribe to our newsletter for the ...

Add Yahoo as a preferred source to see more of our stories on Google. Here's what the lung condition is, what causes it, and how you can expect asthma to be treated if it's diagnosed in you or a loved ...

Three common respiratory diseases seem to be associated with an increased risk of lung cancer, researchers report. The investigators analyzed data from seven studies that included more than 25,000 ...

San Diego-based Gossamer Bio released long-awaited Phase 3 data today for its drug seralutinib, revealing a complex set of results that both challenged and encouraged researchers. The PROSERA study, ...